Bryn Mawr, PA, United States of America

Philip S Schein


 

Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 206(Granted Patents)


Location History:

  • Bethesda, MD (US) (1983)
  • Bryn-Mawr, PA (US) (1987 - 2001)

Company Filing History:


Years Active: 1983-2001

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: **Innovator and Inventor: Philip S. Schein**

Introduction

Philip S. Schein, hailing from Bryn Mawr, PA, is a notable inventor in the field of pharmaceuticals, boasting an impressive portfolio of 14 patents. His work primarily revolves around methods for the administration of specific compounds aimed at reducing adverse side effects during treatment.

Latest Patents

Among his latest contributions to science, Schein's patents include innovative methods for the administration of amifostine and related compounds. These inventions provide methodologies for administering aminoalkyl phosphorothioate and aminoalkyl thiol compounds, which significantly lessen or decrease the adverse side effects typically associated with conventional intravenous administration.

Career Highlights

Schein has worked with prestigious institutions such as Georgetown University and U.S. Bioscience, Inc., which signifies his strong background in research and development. His involvement with these organizations has allowed him to pioneer important advancements in the medical field through his inventive approaches.

Collaborations

Throughout his career, Schein collaborated with talented professionals including Abdolhossen Talebian and Dianna C. Green. These partnerships have further enriched his work, leading to significant contributions that push the boundaries of current medical knowledge.

Conclusion

Philip S. Schein's dedication to innovation in the pharmaceutical industry has resulted in significant advancements through his patent portfolio. His work continues to impact patient treatment outcomes positively, positioning him as a respected figure in the realm of medical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…